Latest Breaking News On - Joseph oliveto - Page 1 : comparemela.com

Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update

Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Israel generalUnited statesKevin gardnerJoseph olivetoKim foxChris calabreseMilestone pharmaceuticalsExchange commissionProgram updatesMilestone pharmaceuticals incAmerican college of cardiologyDrug administrationGlobenewswire incAmerican college of cardiology scientific sessionsChief executive officerRecent program

Charlotte s Milestone Pharmaceuticals advancing heart drug | North Carolina Biotechnology Center

Milestone Pharmaceuticals, a Canadian company with a U.S. subsidiary in Charlotte, is back on track with a potential drug to treat rapid heart rates in certain cardiovascular disorders.The company in late March re-submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of etripamil for the management of paroxysmal supraventricular tachycardia (PSVT), a type of arrhythmia or abnormal heart rhythm.

United statesNorth carolinaDuke universityJi xingJoseph olivetoCorie curtisJi xing pharmaceuticalsDrug administrationResearch triangleResearch triangle regionCarolina biotechnology centerGreater charlotte advisory committeeBiotech centerNcbiotech greater charlotte officeDuke university school of medicineMilestone pharmaceuticals

Milestone Pharmaceuticals Announces Resubmission Of New Drug Application For Etripamil For Treatment In Paroxysmal Supraventricular Tachycardia

Milestone Pharmaceuticals Announces Resubmission Of New Drug Application For Etripamil For Treatment In Paroxysmal Supraventricular Tachycardia
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesIsrael generalJoseph olivetoKim foxPharmaceuticals incMilestone pharmaceuticalsDrug administrationUs securities exchange commissionExchange commissionMilestone pharmaceuticals incNew drug applicationChief executive officerAtrial fibrillationRapid ventricular ratePrivate securities litigation reform actVice president

Milestone resubmits NDA, Aldeyra readies 2nd chance filing

Milestone resubmits NDA, Aldeyra readies 2nd chance filing
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Joseph olivetoMilestone pharmaceuticalsAldeyra therapeutics

FDA Refuse to File Application for Paroxysmal Supraventricular Tachycardia Treatment

Etripamil is an investigational, self-administered, intranasal calcium channel blocker designed to be a rapid-response therapy for episodic cardiovascular conditions.

Joseph olivetoMilestone pharmaceuticalsDrug administrationNew drug application